Rudolf K, Kunkel S, Rudolf H, Herzmann A, Herzmann H
Zentralbl Gynakol. 1986;108(9):551-9.
In 19 patients with Turner's syndrome aged from 12 to 24 years (average age 17.0 years) the influence of mestranol and chlormadinone acetate on both basal and TRH stimulated TSH secretion, total thyroxine (T4), thyroxine binding capacity (TBC) and free thyroxine index (FT4-I) by means of sequential stimulation test (0.5 g arginine hydrochloride/kg body weight, 25 micrograms GnRH and 200 micrograms TRH) was investigated. These investigations were performed before hormonal substitution, during third to 5th cycles of treatment and 4 month after finishing treatment. TSH and T4 serum levels were determined by RIA, TBC by radio reagent assay. The FT4 index was calculated. Mean basal TSH levels both before, during and after hormonal treatment did not differ. Netto TSH level increase were somewhat higher in 8 of the 19 patients during hormonal treatment. TBC and T4 significantly increased under treatment. The rise of FT4 in a few patients under treatment could not be ensured statistically. After finishing treatment the levels of thyroid parameters decreased.
对19例年龄在12至24岁(平均年龄17.0岁)的特纳综合征患者,通过序贯刺激试验(0.5g盐酸精氨酸/千克体重、25微克促性腺激素释放激素和200微克促甲状腺激素释放激素),研究了炔雌醇甲醚和醋酸氯地孕酮对基础及促甲状腺激素释放激素刺激的促甲状腺激素分泌、总甲状腺素(T4)、甲状腺素结合能力(TBC)和游离甲状腺素指数(FT4-I)的影响。这些研究在激素替代治疗前、治疗的第3至5周期以及治疗结束后4个月进行。促甲状腺激素和T4血清水平通过放射免疫分析测定,TBC通过放射试剂分析测定。计算FT4指数。激素治疗前、治疗期间和治疗后的平均基础促甲状腺激素水平无差异。19例患者中有8例在激素治疗期间促甲状腺激素净升高水平略高。治疗期间TBC和T4显著升高。少数治疗患者中FT4升高在统计学上无法确定。治疗结束后甲状腺参数水平下降。